Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine-Reference-Cited by-同舟云学术

Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine

Published:2020-09 Issue:3 Volume:63 Page:279-292
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

George M. Patricia¹,Gladwin Mark T.²³,Graham Brian B.⁴⁵

Affiliation:

1. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado

2. Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

3. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh and UPMC, Pittsburgh, Pennsylvania

4. Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California; and

5. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, California

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Reference86 articles.

1. Heart-Lung Transplantation

2. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

3. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

4. Selexipag for the Treatment of Pulmonary Arterial Hypertension

5. Primary pulmonary hypertension

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the genetic and epigenetic landscape governing intramuscular fat deposition in rabbits: Insights and implications;Food Chemistry: Molecular Sciences;2024-12

2. Classification, Diagnosis, and Medical Treatment of Pulmonary Hypertension;New Insights on Pulmonary Hypertension;2024-03-08

3. Mitochondria-derived Vesicle Packaging as a Novel Therapeutic Mechanism in Pulmonary Hypertension;American Journal of Respiratory Cell and Molecular Biology;2024-01

4. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension;American Journal of Respiratory Cell and Molecular Biology;2023-08

5. Insights into Endothelin Receptors in Pulmonary Hypertension;International Journal of Molecular Sciences;2023-06-16